Four‑Dimensional (4D) Bioprinting: A Systematic Scoping Review of Stimuli‑Responsive Constructs for Applications in Tissue Engineering and Drug Delivery

Göster/ Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2025Yazar
Moghaddasi, MohammadOktay, Büşra
Bingöl, Ayşe Betül
Yanıkoğlu, Reyhan
Çiftçi, Fatih
Üstündağ, Cem Bülent
Üst veri
Tüm öğe kaydını gösterKünye
MOGHADDASİ, Mohammad, Büşra OKTAY, Ayşe Betül BİNGÖL, Reyhan YANIKOĞLU, Fatih ÇİFTÇİ & Cem Bülent ÜSTÜNDAĞ. “Four‑Dimensional (4D) Bioprinting: A Systematic Scoping Review of Stimuli‑Responsive Constructs for Applications in Tissue Engineering and Drug Delivery”. Progress in Additive Manufacturing, 10 (2025): 8985–9024.Özet
Four-dimensional (4D) bioprinting integrates with stimuli-responsive biomaterials to create dynamic constructs capable of
adapting their shape, properties, or bioactivity in response to specific cues. This systematic review, conducted in accordance
with established systematic review guidelines, examines 77 studies sourced from PubMed, Scopus, Web of Science,
and bioRxiv. Extrusion-based bioprinting is predominant (≈80%), with fused deposition modeling, stereolithography, and
inkjet methods also employed. Physical stimuli, including temperature, humidity, and mechanical forces, are the most
commonly utilized alongside less frequently seen chemical and biological cues. Applications in tissue engineering focus
on cartilage, bone, neural, vascular, muscle, and soft-tissue regeneration, where programmable constructs show improved
tissue morphogenesis. In drug delivery and disease-modeling, reactive oxygen species-, pH-, enzyme-, and temperaturetriggered
systems facilitate the targeted release of growth factors, genes, and chemo-/immunotherapeutics. Moreover, most
of the studies employing shape-morphing and shape memory hydrogels focus on broader biomedical applications. These
findings collectively indicate a developing field with the potential to advance next-generation tissue engineering therapies
and drug-release systems.


















